AI eye on the womb: new MRI model aims to spot hidden cancer
NCT ID NCT07269535
First seen Jan 04, 2026 · Last updated May 16, 2026 · Updated 23 times
Summary
This study tests an artificial intelligence (AI) tool that reads MRI scans to tell the difference between common, non-cancerous uterine fibroids and a rare but aggressive cancer called uterine sarcoma. Researchers will enroll 500 women who are scheduled for surgery or long-term follow-up. The goal is to see if the AI can accurately flag which growths are dangerous, helping doctors make faster, more confident decisions and avoid unnecessary surgeries.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AI (ARTIFICIAL INTELLIGENCE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.